
DECHENG CAPITAL LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | NUVB | 25.95M | $96.03M |
![]() | CGON | 6.37M | $256.65M |
![]() | EQ | 4.45M | $6.36M |
![]() | BYSI | 4.29M | $7.76M |
![]() | ACRS | 4.04M | $7.68M |
![]() | AARD | 3.92M | $52.06M |
![]() | UPB | 3.29M | $61.80M |
![]() | ZNTL | 1.32M | $2.00M |
![]() | NAMS | 657K | $18.69M |
![]() | NUVB-WT | 646K | $115.46K |
![]() | RCUS | 548K | $7.45M |
![]() | AURA | 516K | $3.19M |
![]() | PYXS | 327K | $725.52K |
![]() | RVMD | 210K | $9.81M |
![]() | MRUS | 187K | $17.56M |
![]() | CRNX | 143K | $5.96M |
![]() | FDMT | 93K | $805.98K |
![]() | RZLT | 60K | $563.06K |
![]() | KRYS | 32K | $5.70M |
![]() | GRAL | 10K | $572.62K |

Nuvation Bio Inc.
NUVB
Shares Held
25.95M
Value
$96.03M

CG Oncology, Inc. Common stock
CGON
Shares Held
6.37M
Value
$256.65M

Equillium, Inc.
EQ
Shares Held
4.45M
Value
$6.36M

BeyondSpring Inc.
BYSI
Shares Held
4.29M
Value
$7.76M

Aclaris Therapeutics, Inc.
ACRS
Shares Held
4.04M
Value
$7.68M

Aardvark Therapeutics, Inc. Common Stock
AARD
Shares Held
3.92M
Value
$52.06M

Upstream Bio, Inc.
UPB
Shares Held
3.29M
Value
$61.80M

Zentalis Pharmaceuticals, Inc.
ZNTL
Shares Held
1.32M
Value
$2.00M

NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
657K
Value
$18.69M

Nuvation Bio Inc.
NUVB-WT
Shares Held
646K
Value
$115.46K

Arcus Biosciences, Inc.
RCUS
Shares Held
548K
Value
$7.45M

Aura Biosciences, Inc.
AURA
Shares Held
516K
Value
$3.19M

Pyxis Oncology, Inc.
PYXS
Shares Held
327K
Value
$725.52K

Revolution Medicines, Inc.
RVMD
Shares Held
210K
Value
$9.81M

Merus N.V.
MRUS
Shares Held
187K
Value
$17.56M

Crinetics Pharmaceuticals, Inc.
CRNX
Shares Held
143K
Value
$5.96M

4D Molecular Therapeutics, Inc.
FDMT
Shares Held
93K
Value
$805.98K

Rezolute, Inc.
RZLT
Shares Held
60K
Value
$563.06K

Krystal Biotech, Inc.
KRYS
Shares Held
32K
Value
$5.70M

GRAIL, Inc.
GRAL
Shares Held
10K
Value
$572.62K
